DPP4 and cardiovascular disorder: A previous study demonstrated that metformin treatment consistently reduced levels of circulating DPP4 protein in humans with T2DM and cardiovascular disease, but it is uncertain whether this reduction is due to modulating DPP4 synthesis/shedding in specific tissues or due to DPP4 increased clearance (35).